This page provides an independent statistical analysis and educational interpretation of publicly reported results. ClinicalTrials.gov provides the official trial registry record. Numerical trial results on this page are restricted to the results posted in the ClinicalTrials.gov record; calculations added by Clinical Biostats are labelled as such.
1. Trial at a Glance
This page covers the registry results for Qualitative Assessment of Implementing Routine Rapid HIV Testing (NCT00680862), a registered phase not stated study. The primary outcome is Number of Participants Who Completed the Survey.
| Feature | Registry value |
|---|---|
| ClinicalTrials.gov identifier | NCT00680862 |
| Phase | Phase not stated |
| Condition | HIV Infections |
| Allocation | Not Stated |
| Design model | Not Stated |
| Masking | Not Stated |
| Enrollment | 25 |
| Arms in the primary outcome | n/a |
| Lead sponsor | US Department of Veterans Affairs |
| Results posted | Yes |
2. Clinical Question
Population
The study concerns VA employees in the context of implementing routine HIV rapid testing in VA primary care clinics. The registry record does not further describe employee roles, clinic characteristics, eligibility criteria, or the characteristics of people who responded to the survey.
Intervention
The subject of assessment is the implementation of routine rapid HIV testing in primary care clinics within the VA. The record does not specify a testing protocol, implementation strategy, training approach, or other operational details. It identifies the study group as VA employees rather than describing a treatment group.
Comparator
No like-for-like control comparison is described. The registry record identifies one group, VA employees, and notes that this was not a randomized comparison and that allocation was not stated. A separate comparison group or a before-and-after comparison is not reported in the registry record.
Primary question
The primary outcome is the number of participants who completed the survey. The survey was described as gathering participants’ thoughts about implementing HIV rapid testing, with a six-month timeframe. The record does not report the number who completed it or present the survey responses themselves.
3. Trial Design
The registry describes a completed study titled “Qualitative Assessment of Implementing Routine Rapid HIV Testing.” Its stated purpose was to assess implementation of routine rapid HIV testing in primary care clinics within the VA. The sponsor was the US Department of Veterans Affairs. The condition listed is HIV Infections, but the described study focus is implementation and employee survey responses, not a comparison of clinical outcomes among people with HIV.
Enrollment is listed as 25. The sole group description is “VA employees.” The record does not identify a randomized allocation, and it explicitly notes that the study was not a randomized comparison and that allocation was not stated. Accordingly, the group should not be interpreted as one arm in a controlled treatment comparison. A separate control group, assignment procedure, or comparator condition is not reported in the registry record.
The study start is recorded as 2008-06 and primary completion as 2008-09. Its status is completed. The primary outcome is the number of participants who completed a survey about thoughts pertaining to implementation of HIV rapid testing, with a six-month timeframe. The registry lists one outcome measure and zero analyses. It does not report the observed survey-completion count, response content, or a statistical analysis of survey responses.
Further design details—including recruitment procedures, eligibility criteria, how survey responses were collected, and how qualitative material was analyzed—are not reported in the registry record. The enrollment figure describes the study record, but does not establish how many participants completed the survey or contributed analyzable responses.
4. Participant Flow and Accounting
The registry reports how participants moved through each stage of the study. All counts below are exactly as posted; missing counts are not inferred from other stages.
Overall Study
| Stage | Group 1 |
|---|---|
| STARTED | 25 |
| COMPLETED | 25 |
| NOT COMPLETED | 0 |
5. Baseline Characteristics
The table reproduces the baseline characteristics posted in the registry, which describe the participants analysed at baseline and help show whether the randomized groups were comparable.
Population: VA employees
| Characteristic | Unit | Group 1 |
|---|---|---|
| Participants analysed | 25 | |
| Age, Continuous | years | 36 (SD 2) |
| Age, Categorical: <=18 years | Participants | 0 |
| Age, Categorical: Between 18 and 65 years | Participants | 25 |
| Age, Categorical: >=65 years | Participants | 0 |
| Sex: Female, Male: Female | Participants | 0 |
| Sex: Female, Male: Male | Participants | 25 |
| Region of Enrollment: United States | participants | 25 |
6. Primary Endpoint
The registry lists the primary outcome as Number of Participants Who Completed the Survey, measured over 6 months.
| Element | Registry entry |
|---|---|
| Result type | Number |
| Measure of spread | not applicable |
| Unit | participants |
| Endpoint classification | Binary Endpoint |
The primary endpoint is “Number of Participants Who Completed the Survey,” measured in participants. The survey was described as eliciting thoughts about implementation of HIV rapid testing, and the stated timeframe is six months. This is a count outcome: it concerns how many participants completed the survey, rather than a clinical event rate, a treatment effect, or a measured change in health status.
In an implementation assessment, recording survey completion can indicate the amount of participant response available for understanding the implementation experience. It also helps readers distinguish the number enrolled from the number who contributed survey information. Completion alone does not reveal what respondents thought, whether their views were favorable or unfavorable, or whether those views represent employees who did not respond.
The registry record does not give the observed number of survey completers, a denominator for calculating a completion proportion, or the survey findings. It also does not describe a scoring system or a qualitative coding approach. Therefore, the endpoint can be characterized by its stated purpose and measurement unit, but its observed value and the substance of the responses are not reported in the registry record.
7. Why No Re-analysis Is Shown
8. Statistical Interpretation
The registry record establishes the study’s stated focus: assessing implementation of routine rapid HIV testing in VA primary care clinics through survey responses from participants. The recorded enrollment is 25, and the group is described as VA employees. The primary outcome is the number of participants who completed the survey within a six-month timeframe. These details describe the intended subject and measurement, but they do not supply an observed endpoint value.
No survey-completion count or survey-response findings are reported in the registry record. As a result, the record does not show how many enrolled participants completed the survey, what themes or opinions arose, or how consistently employees responded. The enrollment value cannot be treated as the number of completed surveys. Likewise, a study status of completed indicates the recorded status; it does not establish that all enrolled participants completed the survey.
The record lists one outcome measure and zero analyses. It therefore does not report a statistical estimate, confidence interval, hypothesis test, or modeled comparison for the primary outcome. No effect estimate should be inferred from the study title, enrollment, or endpoint description. The registry also does not report a control condition or randomized allocation, so the study is not described as a randomized comparison. Its information cannot be read as a causal estimate comparing an intervention group with a control group.
The outcome is a count of survey completers, while the stated aim is qualitative assessment of implementation. A completion count, if reported, would describe participation in the survey; it would not by itself summarize the content or meaning of survey responses. The registry does not report qualitative findings, coding methods, or a response-rate denominator. Any conclusions about acceptability, feasibility, barriers, facilitators, or the success of implementation would therefore go beyond the reported results.
The adverse-event fields list zero for the recorded serious and other event categories for Group 1, while the deaths field is null and no serious-event terms are listed. These entries do not provide a clinical safety comparison, and a null death field should not be interpreted as a recorded count of zero. Overall, the registry offers basic study and outcome descriptions but does not report results sufficient to quantify survey completion or characterize employee perspectives.
9. Statistical Methods Explained
The registry record supplies a short description of the study’s purpose and primary outcome, but does not report a detailed statistical analysis plan. The following concepts are general explanations of how the listed measurement and design features are usually interpreted; they are not claims that particular procedures were used in this study.
What does a count outcome describe?
A count records how many units meet a stated condition. For this outcome, the unit is a participant and the condition is survey completion. A count is not the same as a proportion: a proportion requires both a numerator and a relevant denominator. The record gives enrollment of 25 but does not report the number completing the survey or specify the denominator used for any completion calculation. It is therefore not possible to derive a completion proportion from the registry entry.
Counts can be useful for describing the amount of collected information, but they do not explain why some people did or did not respond. Nor do they summarize the views expressed in the survey. If survey responses are qualitative, their interpretation depends on the response material and the methods used to organize and analyze it. The registry record does not describe those methods or report the response content.
What can be concluded without a comparator?
A comparative treatment analysis generally needs clearly defined groups and a basis for interpreting differences between them. The record identifies one group, VA employees, and says the study was not a randomized comparison; allocation was not stated. It does not describe a like-for-like control group. Thus, the design information does not support interpreting the study as a randomized estimate of the effect of one implementation approach versus another.
Even when two groups are observed, differences between them can reflect factors other than the intervention or implementation strategy. Random assignment is one approach to balancing such factors on average, but the registry does not report randomization. This general point does not imply that an unreported comparison occurred; it clarifies why the recorded one-group description should not be read as a controlled experiment.
What does a confidence interval mean?
In general, a confidence interval expresses the precision of an estimate under the assumptions of the analysis. A narrower interval indicates greater precision than a wider interval for the same type of estimate. The registry record does not report an estimate or confidence interval for survey completion, so there is no interval to interpret. A confidence interval would not, by itself, address whether a survey sample represents employees who did not respond or whether the measurement captures all relevant implementation experiences.
What is over-dispersion?
In general, over-dispersion occurs when count data vary more than a particular statistical model expects. If it is present, standard errors from a model that assumes less variability can be too small, making the results appear more precise than warranted. Assessing over-dispersion requires suitable count data and an applicable model. The record does not report such a model, count distribution, or analysis, so there is no basis for saying whether over-dispersion was assessed or present in this study.
How should planning assumptions be read?
A sample-size calculation is a planning exercise, not an observed result. The record’s general planning description refers to a two-sided significance level of 0.05, equal allocation between two arms, and a normal approximation, with the target effect expressed as a fraction of an observed effect. It also distinguishes total events for time-to-event calculations from participants per arm for other designs. These are planning assumptions, not evidence that the study used two arms, randomized participants, or conducted an analysis under those assumptions.
The recorded design has one described group and is explicitly not a randomized comparison. The registry does not report a numeric sample-size calculation, a target effect, a statistical justification for enrollment, or a calculation linked to an outcome estimate. No sample-size illustration or power result can be inferred from the enrollment figure alone. A planning calculation, if available, would not be observed power and would not replace the missing outcome results.
The registry lists zero analyses. It does not report an analysis population, a statistical model, a method for handling missing survey responses, or an approach to multiple outcomes or tests. These omissions limit methodological appraisal: the endpoint can be described, but the precision and analysis of its results cannot be evaluated from the registry record.
10. Exact Estimates for Each Arm
No two-arm comparison is shown for this trial, but each arm's result can still be summarized with exact interval estimates computed from the posted counts. The Clopper-Pearson interval is exact and conservative; the Wilson interval is a common closer-to-nominal alternative; the Bayesian credible interval uses a uniform Beta(1, 1) prior. For small groups the three can differ noticeably.
| Arm | Participants | Events | Observed % | Clopper-Pearson 95% CI | Wilson 95% CI | Bayesian 95% credible interval |
|---|---|---|---|---|---|---|
| Group 1 | 25 | 25 | 100.0% | 86.3% to 100.0% | 86.7% to 100.0% | 86.8% to 99.9% |
R code and output
arm <- c("Group 1")
n <- c(25)
events <- c(25)
for (i in seq_along(n)) {
ci <- binom.test(events[i], n[i])$conf.int # Clopper-Pearson exact interval
cr <- qbeta(c(0.025, 0.975), 1 + events[i], 1 + n[i] - events[i]) # Bayesian, uniform Beta(1,1) prior
wi <- (function(x, n) { p <- x / n; z <- qnorm(0.975); d <- 1 + z^2 / n
c((p + z^2 / (2 * n) - z * sqrt(p * (1 - p) / n + z^2 / (4 * n^2))) / d, (p + z^2 / (2 * n) + z * sqrt(p * (1 - p) / n + z^2 / (4 * n^2))) / d) })(events[i], n[i])
cat(sprintf("ARM|%s|%d|%d|%.1f|%.1f|%.1f|%.1f|%.1f|%.1f|%.1f\n", arm[i], n[i], events[i], 100 * events[i] / n[i],
100 * ci[1], 100 * ci[2], 100 * wi[1], 100 * wi[2], 100 * cr[1], 100 * cr[2]))
}
ARM Group 1 25 25 100.0 86.3 100.0 86.7 100.0 86.8 99.911. Multiplicity, Missing Data and Analysis Populations
The registry record lists one outcome measure and zero analyses. It does not report multiple primary endpoints, a hierarchy of outcomes, or a plan for adjusting inference when several outcomes or statistical tests are considered. Multiplicity methods address the increased chance of misleading findings when many hypotheses are tested. Whether such methods were needed or used is not reported in the registry record.
The primary outcome is the number of participants who completed the survey, but the observed count is not reported. The registry also does not give the number of people invited, the number who began but did not complete the survey, or a definition of completion. Without those details, the extent and pattern of missing survey information cannot be assessed. It is also not reported whether incomplete responses were excluded, retained in part, or handled in another way.
The enrolled population is listed as 25, but the analysis population is not reported in the registry record. Enrollment should not be assumed to equal survey completion or the number included in an analysis. The record does not specify whether all VA employees in the group were eligible, whether any participants withdrew, or which responses were considered usable.
These gaps matter because nonresponse can affect the interpretation of survey findings. In general, if the views of respondents differ from the views of nonrespondents, the responses collected may not represent the broader group. This is a general concern, not evidence that such a difference occurred in this study. No information is reported to evaluate it.
12. What the Result Does, and Does Not, Mean
The registry record describes an assessment of routine rapid HIV testing implementation in VA primary care clinics, with survey responses about implementation as its stated subject. It identifies VA employees as the study group, records enrollment of 25, and names survey completion as the primary outcome. These details establish what the study set out to document, not what participants ultimately reported.
The record does not report the number of survey completers or the content of the responses. It therefore does not establish how many employees contributed survey information, what concerns or experiences they described, or whether responses were consistent across participants. The listed enrollment cannot substitute for a completion count. The record’s completed status does not establish that every enrolled person completed the survey.
The information also does not establish whether routine rapid testing was feasible, acceptable, or effective, nor does it estimate a clinical benefit or harm. Those conclusions would require results and analyses that are not reported in the registry record. The study is described as a qualitative implementation assessment, not as a randomized treatment comparison. No causal comparison between an implementation strategy and a control condition is reported.
General statistical interpretation distinguishes what was measured from what the measurement can support. A survey-completion count can describe participation in data collection, while survey responses may provide perspectives on implementation. Neither should be treated as a clinical outcome or a causal effect without supporting evidence. Here, the count and response findings are not reported, so even those descriptive conclusions cannot be drawn from the record.
The most accurate reading is consequently limited: the registry records a completed study with an implementation-focused survey outcome and a VA employee group, but does not post the primary outcome value or findings. The absence of reported results is not evidence that no responses were collected or that implementation had a particular result.
13. Why This Trial Matters Statistically
Implementation research asks how a practice is introduced and experienced in real service settings, rather than only whether a clinical endpoint differs between treatment groups. A qualitative assessment can be relevant because employees may describe practical experiences that a count of clinical outcomes would not capture. The registry’s focus on routine rapid HIV testing in VA primary care clinics places it in that implementation context.
Statistically, the record also illustrates why an endpoint’s label is not the same as a reported result. “Number of Participants Who Completed the Survey” identifies a measurable count, but the registry does not report that count. Enrollment of 25 does not tell readers how many surveys were completed, and it does not reveal what respondents said. Keeping enrollment, outcome measurement, and analysis populations distinct is important when interpreting study records.
The one-group description and the note that this was not a randomized comparison also matter. They prevent an implementation assessment from being mistaken for a controlled estimate of treatment effect. Clear description of design helps readers avoid drawing causal conclusions from information that does not establish a comparator or randomized allocation.
Finally, incomplete reporting limits what can be learned from a registry entry. The stated aim and outcome are useful for understanding the study’s focus, but missing outcome values, response details, and analysis methods prevent assessment of the evidence itself. Recognizing that boundary is an important statistical skill: it distinguishes a study’s question from the results available to answer it.
14. Limitations
- The posted summary statistics are the only data these results rest on; patient-level data, full protocols and statistical analysis plans are not available.
- Recalculated results are simple, unadjusted calculations from posted summaries. They do not replace the sponsor's prespecified analysis.
The main limitation for interpreting this study from the registry record is that the primary outcome value is not reported. Although the endpoint is the number of participants who completed the survey, no completion count or denominator is given. Enrollment of 25 cannot be taken as the number of survey respondents.
The registry does not report survey findings, response content, or a qualitative analysis method. It is therefore not possible to assess what perspectives were expressed, how responses were organized, or whether findings reflect the range of employee experiences. Recruitment methods, eligibility criteria, employee roles, clinic characteristics, and the number invited to participate are also not reported in the registry record.
The design description identifies one group of VA employees and states that the study was not a randomized comparison, with allocation not stated. A control group or like-for-like comparator is not reported. The record consequently does not support a controlled causal comparison. It also does not describe whether the survey was conducted before, during, or after implementation, beyond giving a six-month timeframe for the primary outcome.
Analysis details are sparse: the record lists zero analyses and does not report an analysis population, statistical model, missing-data approach, or uncertainty estimate. The listed adverse-event categories show zero entries for recorded serious and other event counts, while the deaths field is null; these entries do not supply a comparative safety assessment. Together, these limitations mean the registry describes the study’s purpose and planned measurement more clearly than it documents its results.
15. Related Tutorials
16. Related Statistical Calculators
17. Sources
- ClinicalTrials.gov: Qualitative Assessment of Implementing Routine Rapid HIV Testing — NCT00680862.
- Registry record last updated 2014-09-29; status last verified 2014-09.
- Results first posted 2014-09-29.
- Data retrieved from ClinicalTrials.gov on 2026-11-09.
- Group sizes, means, event counts and sponsor-reported p-values are reproduced as posted. Effect estimates, confidence intervals and p-values not attributed to the sponsor are independently calculated from the posted summary statistics.
Continue through the Clinical Biostats statistical pathway
Use this trial's endpoint as a starting point for deeper study of effect measures, confidence intervals, and sample-size planning.
18. Record Summary
NCT00680862 is a completed study titled “Qualitative Assessment of Implementing Routine Rapid HIV Testing,” sponsored by the US Department of Veterans Affairs. The registry lists HIV Infections as the condition and describes an assessment of implementing routine rapid HIV testing in VA primary care clinics. Enrollment is 25, and the described group consists of VA employees.
The primary outcome is the number of participants who completed a survey about thoughts pertaining to implementation of HIV rapid testing, with a six-month timeframe. The record lists one outcome measure and zero analyses. It does not report the survey-completion count or survey findings. The design is not described as a randomized comparison, and allocation is not stated. A comparator, detailed analysis methods, and the number of participants included in an analysis are not reported in the registry record.